Quick Answer
UTAH MEDICAL PRODUCTS INC reported Stockholders Equity of $119.27 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +1.6% in Stockholders Equity from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $40.00 million | Q3 2011: $40.37 million | Q1 2012: $44.53 million | Q2 2012: $45.55 million | Q3 2012: $48.71 million | Q1 2013: $50.72 million | Q2 2013: $52.64 million | Q3 2013: $57.08 million | Q1 2014: $62.94 million | Q2 2014: $64.97 million | Q3 2014: $64.22 million | Q1 2015: $63.84 million | Q2 2015: $68.19 million | Q3 2015: $68.35 million | Q1 2016: $71.66 million | Q2 2016: $71.07 million | Q3 2016: $72.67 million | Q1 2017: $72.54 million | Q2 2017: $77.25 million | Q3 2017: $81.20 million | Q1 2018: $82.69 million | Q2 2018: $83.36 million | Q3 2018: $88.83 million | Q1 2019: $92.18 million | Q2 2019: $93.91 million | Q3 2019: $94.99 million | Q1 2020: $94.39 million | Q2 2020: $95.29 million | Q3 2020: $98.42 million | Q1 2021: $104.88 million | Q2 2021: $107.37 million | Q3 2021: $109.98 million | Q4 2021: $107.14 million | Q1 2022: $109.17 million | Q2 2022: $107.47 million | Q3 2022: $108.19 million | Q4 2022: $114.25 million | Q1 2023: $118.02 million | Q2 2023: $121.76 million | Q3 2023: $123.70 million | Q1 2024: $127.74 million | Q2 2024: $124.05 million | Q3 2024: $124.20 million | Q1 2025: $117.05 million | Q2 2025: $117.53 million | Q3 2025: $118.25 million.
- Over the full 16 years of available data (2010 to 2025), UTAH MEDICAL PRODUCTS INC's Stockholders Equity has grown by 215.6%.
- Historical annual values: Fiscal year 2025: $119.27 million | Fiscal year 2024: $117.43 million | Fiscal year 2023: $128.31 million | Fiscal year 2022: $114.25 million | Fiscal year 2021: $107.14 million | Fiscal year 2020: $102.82 million | Fiscal year 2019: $101.09 million | Fiscal year 2018: $88.99 million | Fiscal year 2017: $78.12 million | Fiscal year 2016: $69.24 million | Fiscal year 2015: $69.65 million | Fiscal year 2014: $64.56 million | Fiscal year 2013: $60.58 million | Fiscal year 2012: $50.97 million | Fiscal year 2011: $40.76 million | Fiscal year 2010: $37.79 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: